AI Article Synopsis

  • This study looked at how a treatment called selective internal radiation therapy (SIRT) can help patients with liver tumors by making other parts of the liver grow larger, which is important for surgery.
  • Researchers focused on different factors that could affect how much the liver grows after treatment, using scans and measurements over time.
  • They found that when a certain amount of the non-tumor liver got enough radiation, it helped increase the future liver size, especially in patients who originally had less than 30% healthy liver.

Article Abstract

Introduction: Volume changes induced by selective internal radiation therapy (SIRT) may increase the possibility of tumor resection in patients with insufficient future liver remnant (FLR). The aim was to identify dosimetric and clinical parameters associated with contralateral hepatic hypertrophy after lobar/extended lobar SIRT with Y-resin microspheres.

Materials And Methods: Patients underwent Y PET/CT after lobar or extended lobar (right + segment IV) SIRT. Y voxel dosimetry was retrospectively performed (PLANET Dose; DOSIsoft SA). Mean absorbed doses to tumoral/non-tumoral-treated volumes (NTL) and dose-volume histograms were extracted. Clinical variables were collected. Patients were stratified by FLR at baseline (T0-FLR): < 30% (would require hypertrophy) and ≥ 30%. Changes in volume of the treated, non-treated liver, and FLR were calculated at < 2 (T1), 2-5 (T2), and 6-12 months (T3) post-SIRT. Univariable and multivariable regression analyses were performed to identify predictors of atrophy, hypertrophy, and increase in FLR. The best cut-off value to predict an increase of FLR to ≥ 40% was defined using ROC analysis.

Results: Fifty-six patients were studied; most had primary liver tumors (71.4%), 40.4% had cirrhosis, and 39.3% had been previously treated with chemotherapy. FLR in patients with T0-FLR < 30% increased progressively (T0: 25.2%; T1: 32.7%; T2: 38.1%; T3: 44.7%). No dosimetric parameter predicted atrophy. Both NTL-Dmean and NTL-V30 (fraction of NTL exposed to ≥ 30 Gy) were predictive of increase in FLR in patients with T0 FLR < 30%, the latter also in the total cohort of patients. Hypertrophy was not significantly associated with tumor dose or tumor size. When ≥ 49% of NTL received ≥ 30 Gy, FLR increased to ≥ 40% (accuracy: 76.4% in all patients and 80.95% in T0-FLR < 30% patients).

Conclusion: NTL-Dmean and NTL exposed to ≥ 30 Gy (NTL-V30) were most significantly associated with increase in FLR (particularly among patients with T0-FLR < 30%). When half of NTL received ≥ 30 Gy, FLR increased to ≥ 40%, with higher accuracy among patients with T0-FLR < 30%.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-021-05272-9DOI Listing

Publication Analysis

Top Keywords

t0-flr 30%
20
increase flr
16
≥ 30 gy
16
≥ 40%
12
flr patients
12
patients t0-flr
12
flr
11
patients
10
future liver
8
liver remnant
8

Similar Publications

Article Synopsis
  • This study looked at how a treatment called selective internal radiation therapy (SIRT) can help patients with liver tumors by making other parts of the liver grow larger, which is important for surgery.
  • Researchers focused on different factors that could affect how much the liver grows after treatment, using scans and measurements over time.
  • They found that when a certain amount of the non-tumor liver got enough radiation, it helped increase the future liver size, especially in patients who originally had less than 30% healthy liver.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!